Back to search

Article

Deep learning predicts HRD and platinum response from histology slides in breast and ovarian cancer

2023-02-26

Abstract excerpt

<h4>ABSTRACT</h4> Breast and ovarian cancers harboring homologous recombination deficiencies (HRD) can benefit from platinum-based chemotherapies and PARP inhibitors. Standard diagnostic tests for detecting HRD utilize molecular profiling, which is not universally available especially for medically underserved populations. Here, we trained a deep learning approach for predicting genomically derived HRD scores fro...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
873ac60a-c54c-5a4a-8972-8386f1461a78
DOI
10.1101/2023.02.23.23285869
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Deep learning predicts HRD and platinum response from histology slides in breast and ovarian cancerDOI 10.1101/2023.02.23.23285869
Select a neighboring publication to make it the new centre.